sanofi-aventis

(NYSE:SNY)
  Jun 30, 2008 Dec 31, 2007 Sep 30, 2007
Cash Flow Statement
Cash At Beginning Of Period 2,694,000 1,684,000
Cash At End Of Period 1,490,000 2,499,000
Net Change In Cash And Cash Equivalents -1,204,000 815,000
Effect Of Exchange Rate Changes -48,000 -18,000
Net Income Or Loss 3,677,000 7,686,000
Cash From Operating Activities
Depreciation Expenses 3,583,000 6,811,000
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes -568,000 -2,155,000
Operating Gains Or Losses 124,000
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables -615,000 -88,000
Increase Or Decrease In Inventories -111,000 -130,000
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities -234,000 -228,000
Increase Or Decrease In Other Working Capital
Other Non Cash Items -124,000 -739,000
Net Cash From Continuing Operations -499,000 -904,000
Net Cash From Discontinued Operations 5,109,000 10,377,000
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment 160,000 480,000
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -1,256,000 -2,351,000
Acquisitions
Purchase Of Long Term Investments -313,000
Purchase Of Short Term Investments -323,000
Other Investing Changes Net 6,000
Cash From Discontinued Investing Activities
Net Cash From Investing Activities -1,089,000 -2,506,000
Cash From Financing Activities
Issuance Of Debt 33,000 430,000
Issuance Of Capital Stock -28,000 -3,759,000
Repayment Of Debt -1,929,000 -2,637,000
Repurchase Of Capital Stock -4,255,000 -3,452,000
Payment Of Cash Dividends -6,000 -13,000
Net Other Financing Charges -6,000 -13,000
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -5,177,000 -7,039,000